Sammy Elmariah, MD, MPH Joins AusculSciences Advisory Board
Interventional cardiologist to help guide development of company’s solutions to detect cardiac conditions.
OTTAWA, CANADA – September 29, 2020 – AusculSciences™, a pioneer in developing advanced acoustic technologies to detect cardiovascular and pulmonary conditions, today announced that Dr. Sammy Elmariah, MD, MPH, FACC, FAHA, FSCAI has joined the company’s medical advisory board. He is currently an interventional cardiologist at Massachusetts General Hospital and the Director of Interventional Cardiology Research and is an Assistant Professor of Medicine at Harvard Medical School.
Dr. Elmariah’s research focuses on clinical and translational efforts to improve clinical care provided to patients with valvular heart disease. His research is supported by the National Institutes of Health, the American Heart Association, and the Department of Defense. Dr. Elmariah is an MGH Heart Center Hassenfeld Research Scholar and has been awarded the Jeremiah Stamler Distinguished Young Investigator Award and an American College of Cardiology Young Investigator Award.
is a highly respected expert whom I am extremely pleased to have as part of our medical advisory board,” said Dr. Marina Vernalis, DO, FACC, SVP and Chief Medical Officer of AusculSciences. “His work in aortic stenosis research will help us immensely as we continue development on products to assist physicians in diagnosing valvular heart disease”.
“As early detection of coronary artery disease, aortic stenosis and other cardiac conditions becomes increasingly important for improving outcomes for patients, providers need faster and more accurate non-invasive ways to screen for disease,” said Dr. Elmariah. “I look forward to serving on the medical advisory board of AusculSciences and contributing to developing and advancing the kind of technology that can benefit patients around the world.”
Dr. Elmariah graduated from the University of Pennsylvania School of Medicine, completed his internal medicine residency training at the Hospital of the University of Pennsylvania, completed his fellowship in cardiovascular medicine at the Mount Sinai Hospital in New York and subsequently, completed training in interventional cardiology and structural heart disease interventions at the Massachusetts General Hospital.
AusculSciences is a medical device, services, and software solutions company dedicated to the development of acoustic technologies to detect cardiovascular and pulmonary conditions. AusculSciences’ innovative approach provides physicians and nurses with actionable data to support clinical decision making, reduce the cost of diagnoses while improving patient care and provider safety.
For more information, contact:
Vice President, Business Development
Tel: +1-613-763-0088 ext. 102